MCK — McKesson Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual cashflow statement for McKesson, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,340	1,287	3,722	3,160	3,481
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	717	1,731	879	1,149	1,204
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	8,186	82	440	-27	874
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	4,542	3,894	5,629	4,314	6,085
Capital Expenditures	-641	-535	-558	-687	-859
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	226	446	16	-385	126
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities	-415	-89	-542	-1,072	-733
Financing Cash Flow Items	-199	-1,414	-324	-175	-554
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,693	-6,321	-4,368	-3,342	-3,965
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,373	-2,461	744	-94	1,371